Cargando…
Prevalence of hepatic steatosis and associated factors in Iranian patients with chronic hepatitis C
Background: Hepatic steatosis is commonly observed in patients with chronic hepatitis C (CHC). Many studies indicate a relationship between steatosis and fibrosis progression. The aim of this study was to analyze the prevalence of hepatic steatosis and related factors in Iranian CHC patients. Method...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iran University of Medical Sciences
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898852/ https://www.ncbi.nlm.nih.gov/pubmed/27390692 |
_version_ | 1782436403248889856 |
---|---|
author | Poortahmasebi, Vahdat Emami Aleagha, Mohammad Sajad Amiri, Mehdi Qorbani, Mostafa Farahmand, Mohammad Asayesh, Hamid Alavian, Seyed Moayed |
author_facet | Poortahmasebi, Vahdat Emami Aleagha, Mohammad Sajad Amiri, Mehdi Qorbani, Mostafa Farahmand, Mohammad Asayesh, Hamid Alavian, Seyed Moayed |
author_sort | Poortahmasebi, Vahdat |
collection | PubMed |
description | Background: Hepatic steatosis is commonly observed in patients with chronic hepatitis C (CHC). Many studies indicate a relationship between steatosis and fibrosis progression. The aim of this study was to analyze the prevalence of hepatic steatosis and related factors in Iranian CHC patients. Methods: One hundred and fifteen consecutive patients with CHC were enrolled which were treatment- naïve. The patients were divided into groups with and without steatosis according to the result of liver biopsy (58.3% and 41.7%, respectively). Demographic, histological, biochemical and virological factors were examined and compared in all patients. Results: In terms of host factors, body mass index (BMI), triglyceride, fasting blood glucose (FBG), necroinflammatory activity and severity in fibrosis of CHC patients with steatosis was significantly higher than the patients without steatosis. Of viral factors, HCV viral load was not significantly altered in patients with steatosis. Moreover, HCV genotypes did not meet such association. Using multivariate regression analysis, parameters of BMI values, FBG level and stage of fibrosis were independently associated with steatosis. Conclusion: Our data indicate that CHC patients are more susceptible to development of hepatic steatosis. Based on our results, grade of steatosis appears to be associated with hepatic fibrosis progression rate in CHC patients. |
format | Online Article Text |
id | pubmed-4898852 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Iran University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-48988522016-07-07 Prevalence of hepatic steatosis and associated factors in Iranian patients with chronic hepatitis C Poortahmasebi, Vahdat Emami Aleagha, Mohammad Sajad Amiri, Mehdi Qorbani, Mostafa Farahmand, Mohammad Asayesh, Hamid Alavian, Seyed Moayed Med J Islam Repub Iran Original Article Background: Hepatic steatosis is commonly observed in patients with chronic hepatitis C (CHC). Many studies indicate a relationship between steatosis and fibrosis progression. The aim of this study was to analyze the prevalence of hepatic steatosis and related factors in Iranian CHC patients. Methods: One hundred and fifteen consecutive patients with CHC were enrolled which were treatment- naïve. The patients were divided into groups with and without steatosis according to the result of liver biopsy (58.3% and 41.7%, respectively). Demographic, histological, biochemical and virological factors were examined and compared in all patients. Results: In terms of host factors, body mass index (BMI), triglyceride, fasting blood glucose (FBG), necroinflammatory activity and severity in fibrosis of CHC patients with steatosis was significantly higher than the patients without steatosis. Of viral factors, HCV viral load was not significantly altered in patients with steatosis. Moreover, HCV genotypes did not meet such association. Using multivariate regression analysis, parameters of BMI values, FBG level and stage of fibrosis were independently associated with steatosis. Conclusion: Our data indicate that CHC patients are more susceptible to development of hepatic steatosis. Based on our results, grade of steatosis appears to be associated with hepatic fibrosis progression rate in CHC patients. Iran University of Medical Sciences 2016-02-07 /pmc/articles/PMC4898852/ /pubmed/27390692 Text en © 2016 Iran University of Medical Sciences http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0), which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly. |
spellingShingle | Original Article Poortahmasebi, Vahdat Emami Aleagha, Mohammad Sajad Amiri, Mehdi Qorbani, Mostafa Farahmand, Mohammad Asayesh, Hamid Alavian, Seyed Moayed Prevalence of hepatic steatosis and associated factors in Iranian patients with chronic hepatitis C |
title | Prevalence of hepatic steatosis and associated factors in Iranian patients with chronic hepatitis C |
title_full | Prevalence of hepatic steatosis and associated factors in Iranian patients with chronic hepatitis C |
title_fullStr | Prevalence of hepatic steatosis and associated factors in Iranian patients with chronic hepatitis C |
title_full_unstemmed | Prevalence of hepatic steatosis and associated factors in Iranian patients with chronic hepatitis C |
title_short | Prevalence of hepatic steatosis and associated factors in Iranian patients with chronic hepatitis C |
title_sort | prevalence of hepatic steatosis and associated factors in iranian patients with chronic hepatitis c |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898852/ https://www.ncbi.nlm.nih.gov/pubmed/27390692 |
work_keys_str_mv | AT poortahmasebivahdat prevalenceofhepaticsteatosisandassociatedfactorsiniranianpatientswithchronichepatitisc AT emamialeaghamohammadsajad prevalenceofhepaticsteatosisandassociatedfactorsiniranianpatientswithchronichepatitisc AT amirimehdi prevalenceofhepaticsteatosisandassociatedfactorsiniranianpatientswithchronichepatitisc AT qorbanimostafa prevalenceofhepaticsteatosisandassociatedfactorsiniranianpatientswithchronichepatitisc AT farahmandmohammad prevalenceofhepaticsteatosisandassociatedfactorsiniranianpatientswithchronichepatitisc AT asayeshhamid prevalenceofhepaticsteatosisandassociatedfactorsiniranianpatientswithchronichepatitisc AT alavianseyedmoayed prevalenceofhepaticsteatosisandassociatedfactorsiniranianpatientswithchronichepatitisc |